The effect of a subnormal vitamin B-6 status on homocysteine metabolism

被引:206
作者
Ubbink, JB
vanderMerwe, A
Delport, R
Allen, RH
Stabler, SP
Riezler, R
Vermaak, WJH
机构
[1] UNIV COLORADO,CTR HLTH,DIV HEMATOL,DENVER,CO 80262
[2] SEVERIMED,D-48163 MUNSTER,GERMANY
关键词
folate; methionine; coronary heart disease; vitamin B-12; cystathionine;
D O I
10.1172/JCI118763
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Homocysteine, an atherogenic amino acid, is either remethylated to methionine or metabolized to cysteine by the transsulfuration pathway. The biochemical conversion of homocysteine to cysteine is dependent upon two consecutive, vitamin B-6-dependent reactions. To study the effect of a selective vitamin B-6 deficiency on transsulfuration, we performed oral methionine load tests on 22 vitamin B-6-deficient asthma patients treated with theophylline (a vitamin B-6 antagonist) and 24 age- and sex-matched controls with a normal vitamin B-6 status. Both groups had normal circulating vitamin B-12 and folate concentrations, Methionine loading resulted in significantly higher increases in circulating total homocyst(e)ine (P < 0.01) and cystathionine (P < 0.05) concentrations in vitamin B-6-deficient patients compared with controls. 6 wk of vitamin B-6 supplementation (20 mg/d) significantly (P < 0.05) reduced post-methionine load increases in circulating total homocyst(e)ine concentrations in deficient subjects, but had no significant effect on the increase in total homocyst(e)ine concentrations in controls. The increases in post-methionine load circulating cystathionine concentrations were significantly (P < 0.01) reduced in both groups after vitamin supplementation. It is concluded that a vitamin B-6 deficiency may contribute to impaired transsulfuration and an abnormal methionine load test, which is associated with premature vascular disease.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 52 条
[51]   HOMOCYSTEINEMIA, ISCHEMIC-HEART-DISEASE, AND THE CARRIER STATE FOR HOMOCYSTINURIA [J].
WILCKEN, DEL ;
REDDY, SG ;
GUPTA, VJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (04) :363-370
[52]  
WU LL, 1994, CLIN CHEM, V40, P552